Supplementary Figure 1 from Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study

Read full text Summarise with VIRAT
Authors: Mariano Ponz‐Sarvisé, Sun Young Rha, Carlos Gomez‐Roca, Laura Ortega Morán, Sanjeev Singh Gill, Giampaolo Tortora, Ravit Geva, Esma Saâda-Bouzid, Armando Santoro, Tae Hun Kim, Daniel Heudobler, Corina E. Dutcus
+8 more Chinyere E. Okpara, Razi Ghori, Yiwei Zhang, Amir Vajdi, EJ Dettman, Fan Jin, Roman Groisberg, Ronnie Shapira‐Frommer
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Oncoprint from central WES in participants with biliary tract cancer (cohort F)

Fields of Study & Subjects

Cholangiocarcinoma and Gallbladder Cancer Studies Pancreatic and Hepatic Oncology Research Gastric Cancer Management and Outcomes

Publication details

Publication date
26 March 2026
Language
EN